Exane Derivatives’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-55
| Closed | -$516 | – | 921 |
|
|
2022
Q1 | $516 | Buy |
+55
| New | +$516 | ﹤0.01% | 850 |
|
|
2021
Q4 | – | Sell |
-55
| Closed | -$536 | – | 959 |
|
|
2021
Q3 | $536 | Hold |
55
| – | – | ﹤0.01% | 912 |
|
|
2021
Q2 | $501 | Sell |
55
-10,979
| -100% | -$100K | ﹤0.01% | 923 |
|
|
2021
Q1 | $127K | Sell |
11,034
-1,129
| -9% | -$13K | 0.04% | 371 |
|
|
2020
Q4 | $117K | Buy |
12,163
+2,302
| +23% | +$22.2K | 0.03% | 373 |
|
|
2020
Q3 | $88.8K | Buy |
9,861
+4,606
| +88% | +$41.5K | 0.03% | 295 |
|
|
2020
Q2 | $64.8K | Sell |
5,255
-39,807
| -88% | -$491K | 0.02% | 317 |
|
|
2020
Q1 | $405K | Sell |
45,062
-10,200
| -18% | -$91.6K | 0.11% | 126 |
|
|
2019
Q4 | $582K | Buy |
55,262
+2,169
| +4% | +$22.9K | 0.11% | 148 |
|
|
2019
Q3 | $365K | Hold |
53,093
| – | – | 0.07% | 177 |
|
|
2019
Q2 | $490K | Buy |
53,093
+43,782
| +470% | +$404K | 0.09% | 162 |
|
|
2019
Q1 | $146K | Buy |
+9,311
| New | +$146K | 0.03% | 248 |
|
|
2017
Q4 | – | Sell |
-32,467
| Closed | -$571K | – | 593 |
|
|
2017
Q3 | $571K | Buy |
+32,467
| New | +$571K | 0.11% | 117 |
|